Skip to main content

ABBV-IMAB-TJC4

ABBV-IMAB-TJC4 is a monoclonal antibody under development for the potential indications of: AML, MDS, Multiple Myeloma and solid tumor indications.

Type of Molecule

Biologic

Target

CD47

Product Type

Line Extension
Potential Indication Region Phase (1, 2, 3, Submitted)
Hematologic Malignancies and Solid Tumors n/a
Phase 1